Literature DB >> 21257152

Relation of intraocular concentrations of inflammatory factors and improvement of macular edema after vitrectomy in branch retinal vein occlusion.

Yoko Okunuki1, Yoshihiko Usui, Naomichi Katai, Takeshi Kezuka, Masaru Takeuchi, Hiroshi Goto, Yoshihiro Wakabayashi.   

Abstract

PURPOSE: To investigate the association of intraocular concentrations of inflammatory factors and improvement of macular edema after vitrectomy for patients with macular edema in branch retinal vein occlusion (BRVO).
DESIGN: Retrospective case-control study.
METHODS: Seventeen patients with BRVO who underwent vitreous surgery for macular edema and 15 control patients were enrolled from Hachioji Medical Center of Tokyo Medical University. The concentrations of eight inflammatory factors were measured in vitreous and aqueous fluids obtained at the time of vitrectomy using a flow cytometer. Macular thickness was measured by optical coherence tomography before and one, three, and six months after surgery. Correlations between the concentrations of inflammatory factors and macular thickness were statistically analyzed.
RESULTS: Higher aqueous and vitreous concentrations of vascular endothelial growth factor (VEGF) and interleukin (IL)-8 were significantly correlated with a greater difference in macular thickness between before and six months after surgery (vitreous VEGF, P=.047; aqueous VEGF, P=.032; vitreous IL-8, P=.016; and aqueous IL-8, P=.032). Higher intraocular concentrations of monokine induced by interferon γ (Mig) were significantly correlated with a smaller degree of macular thickness six months after surgery (vitreous Mig, P=.038; aqueous Mig, P=.009).
CONCLUSION: High preoperative VEGF, IL-8, and Mig concentrations were associated with improvement of macular edema six months after vitreous surgery in patients with macular edema attributable to BRVO.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21257152     DOI: 10.1016/j.ajo.2010.09.030

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  10 in total

Review 1.  Possible roles of anti-type II collagen antibody and innate immunity in the development and progression of diabetic retinopathy.

Authors:  Tsunehiko Ikeda; Kimitoshi Nakamura; Teruyo Kida; Hidehiro Oku
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-08-11       Impact factor: 3.535

2.  Influence of retinal ischemia on macular function after pars plana vitrectomy for macular edema with branch retinal vein occlusion.

Authors:  Hidetaka Noma; Katsunori Shimada; Tatsuya Mimura
Journal:  Int Ophthalmol       Date:  2013-03-29       Impact factor: 2.031

3.  Twelve-month experience with Ozurdex for the treatment of macular edema associated with retinal vein occlusion.

Authors:  W J Mayer; A Wolf; M Kernt; D Kook; A Kampik; M Ulbig; C Haritoglou
Journal:  Eye (Lond)       Date:  2013-04-19       Impact factor: 3.775

4.  Strategy for the management of macular edema in retinal vein occlusion: the European VitreoRetinal Society macular edema study.

Authors:  Ron A Adelman; Aaron J Parnes; Silvia Bopp; Ihab Saad Othman; Didier Ducournau
Journal:  Biomed Res Int       Date:  2015-01-29       Impact factor: 3.411

5.  Relationship between distribution and severity of non-perfusion and cytokine levels and macular thickness in branch retinal vein occlusion.

Authors:  Gahyung Ryu; Donghyoun Noh; Jano van Hemert; SriniVas R Sadda; Min Sagong
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

Review 6.  A Review of Intraocular Biomolecules in Retinal Vein Occlusion: Toward Potential Biomarkers for Companion Diagnostics.

Authors:  Bingjie Wang; Xiao Zhang; Huan Chen; Adrian Koh; Chan Zhao; Youxin Chen
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

7.  Peripheral fluorescein angiographic findings in fellow eyes of patients with branch retinal vein occlusion.

Authors:  Irena Tsui; Asima Bajwa; Valentina Franco-Cardenas; Carolyn K Pan; Hanna Y Kim; Steven D Schwartz
Journal:  Int J Inflam       Date:  2013-03-31

8.  Macular hole formation following intravitreal injection of ranibizumab for branch retinal vein occlusion: a case report.

Authors:  Daisuke Muramatsu; Ryosuke Mitsuhashi; Takuya Iwasaki; Hiroshi Goto; Masahiro Miura
Journal:  BMC Res Notes       Date:  2015-08-19

Review 9.  Clinical Trials in Branch Retinal Vein Occlusion.

Authors:  Tandava Krishnan Panakanti; Jay Chhablani
Journal:  Middle East Afr J Ophthalmol       Date:  2016 Jan-Mar

10.  Long-term management of non-ischemic central retinal vein occlusion with fluocinolone acetonide intravitreal implant 190 μg (ILUVIEN®).

Authors:  João Coelho; Bernardete Pessoa; Angelina Meireles
Journal:  Ther Adv Ophthalmol       Date:  2019-01-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.